Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Feb 21, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary:**
This clinical trial is looking at the long-term effects of using a special mesh (called the Parietex™ TCM Parietal Prosthesis) during a terminal colostomy surgery. A colostomy is a procedure where part of the bowel is brought out through the abdomen, often needed for patients with certain health conditions. The goal of this study is to see how many patients develop a parastomal hernia (a type of bulge that can occur around the stoma) five years after their surgery—comparing those who had the mesh placed with those who did not.
To be eligible for this trial, you must be part of a health insurance program and have had a colostomy for five years as part of the earlier GRECCAR 07 study. Participants will be closely monitored to assess their health and any complications related to the colostomy. This study is currently recruiting participants, and it's important to know that you cannot join if you are part of another study or if you are pregnant or breastfeeding. This research aims to improve the understanding of how mesh may help prevent hernias after colostomy surgery, which can help doctors make better treatment decisions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient must be affiliated with a health insurance programme
- • Patient was included in the GRECCAR 07 cohort (PHRC National 2011; N° RCB: 2011-A01572-39 - ClinicalTrials.gov ID: NCT01380860)
- • Patient received colostomy 5 years ago
- Exclusion Criteria:
- • The subject is participating in another category I interventional study, or is in a period of exclusion determined by a previous study
- • The subject signals opposition to participating in the study
- • The patient is under safeguard of justice or state guardianship
- • The patient is pregnant or breastfeeding
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, , France
Lille, , France
Bordeaux, , France
Lyon, , France
Clichy, , France
Grenoble, , France
Nîmes, , France
Marseille, , France
Besançon, , France
Clermont Ferrand, , France
Marseille, , France
Montpellier, , France
Nantes, , France
Paris, , France
Rouen, , France
Toulouse, , France
Patients applied
Trial Officials
Michel Prudhomme, MD
Principal Investigator
CHU Nimes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials